Clinical trial
Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer
NCT02846103 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer
- Lead sponsor
- Centre Hospitalier Universitaire de Besancon
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- September 14, 2023
- Enrollment
- 321 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer